Skip to main content

Table 2 Plasma levels of B-vitamin, related vitamers, and metabolites at baseline

From: B-vitamins, related vitamers, and metabolites in patients with quiescent inflammatory bowel disease and chronic fatigue treated with high dose oral thiamine

 

Analysis

Patients with chronic fatigue (n = 40)

Patients with no fatigue (n = 20)

p-value

Vitamin B1

Thiamine (nmol/L)

2.9 (1.8 to 5.3)

2.7 (2.0 to 5.3)

0.97

Thiamine monophosphate (nmol/L)

8.3 (5.4 to 9.8)

8.3 (6.0 to 11.0)

0.70

Vitamin B2

Riboflavin (nmol/L)

12.1 (6.9 to 18.5)

11.2 (7.7 to 19.7)

0.66

Flavin mononucleotide (nmol/L)

11.1 (8.4 to 13.7)

14.2 (10.9 to 17.0)

0.02

Vitamin B3

Nicotinic acid (nmol/L)

368 (279 to 476)

372 (311 to 471)

0.72

N1-methylnicotinamide (nmol/L)

361 (264 to 547)

439 (302 to 516)

0.66

Vitamin B6

Pyridoxal 5ʹ-phosphate (nmol/L)

52.0 (36.0 to 86.4)

41.6 (33.8 to 56.2)

0.16

Pyridoxal (nmol/L)

12.6 (9.6 to 21.0)

9.5 (8.4 to 12.8)

0.06

4-Pyridoxic acid (nmol/L)

19.7 (12.0 to 38.6)

12.6 (11.6 to 26.5)

0.32

Tryptophan metabolites

Kynurenine (μmol/L)

62.8 (55.1 to 73.3)

60.9 (52.7 to 65.9)

0.26

Kynurenic acid (nmol/L)

1.6 (1.3 to 1.9)

1.6 (1.3 to 1.7)

0.86

Anthranilic acid (nmol/L)

44.8 (31.9 to 57.8)

50.4 (44.1 to 67.0)

0.07

3-Hydroxykynurenine (nmol/L)

43.0 (36.3 to 57.1)

43.0 (34.1 to 57.3)

0.99

Xanthurenic acid (nmol/L)

17.1 (12.8 to 23.6)

20.0 (12.5 to 22.1)

0.55

3-Hydroxyanthranilic acid (nmol/L)

9.9 (7.8 to 12.7)

10.1 (9.0 to 11.3)

0.83

Picolinic acid (nmol/L)

40.1 (29.9 to 50.4)

42.8 (29.7 to 57.4)

0.47

Quinolinic acid (nmol/L)

38.9 (23.6 to 47.3)

43.3 (33.6 to 58.3)

0.21

Nicotine metabolites

Cotinine (nmol/L)

124 (79 to 152)

111 (91 to 194)

0.95

Trans-3ʹ-hydroxycotinine (nmol/L)

0.31 (0.20 to 0.46)

0.25 (0.16 to 0.39)

0.34

Other

Cystathionine (μmol/L)

14.5 (10.8 to 18.8)

13.5 (10.3 to 17.1)

0.58

Trigonelline (μmol/L)

0.69 (0.38 to 2.50)

1.02 (0.47 to 3.38)

0.44

  1. Comparison of 40 chronic fatigued and 20 non-fatigued patients with quiescent inflammatory bowel disease (IBD). Results are showed as median and interquartile range in parentheses